Tepadina Injection, Powder, Lyophilized, For Solution
Product Images NDC 70121-1687

31 FDA label images from Amneal Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Tepadina (NDC 70121-1687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Tepadina 1)

Figure A (Tepadina 1)
Chemical structure of Thiotepa, the active ingredient in TEPADINA injection powder for solution. The diagram shows a phosphorus atom double bonded to sulfur and connected to three nitrogen atoms each part of three-membered rings.*
FDA Label Image

Figure B (Tepadina 2)

Figure B (Tepadina 2)
Label for TEPADINA 15 mg/vial (thiotepa) injection powder for solution. Designed for intravenous, intracavitary, or intravesical use. Single dose vial with a caution for cytotoxic agent, Rx only. Distributed by Amneal Pharmaceuticals LLC for ADIENNE SA. Label includes NDC 70121-1630-1 and barcode, with dimensions 66 mm by 24 mm.*
FDA Label Image

Figure B-400mg Bag (Tepadina 3)

Figure B-400mg Bag (Tepadina 3)
Carton packaging label for TEPADINA 15 mg/vial (thiotepa) injection powder for solution. The label states it is for intravenous, intracavitary, or intravesical use, and single-dose vial. It includes storage instructions for refrigerated temperatures and cautions that the product is cytotoxic. Distributed by Amneal Pharmaceuticals LLC. Barcode and NDC 70121-1630-1 are visible.*
FDA Label Image

Figure C (Tepadina 4)

Figure C (Tepadina 4)
Label for TEPADINA 100 mg/vial (thiotepa) injection powder for solution. The label indicates routes of administration as intravenous, intracavitary, or intravesical use. It includes warnings such as 'Caution: Cytotoxic agent' and 'Rx Only'. The label is distributed by Amneal Pharmaceuticals LLC for ADIENNE SA and displays an NDC number 70121-1631-1 along with lot and expiration placeholders and a barcode.*
FDA Label Image

Figure D (Tepadina 5)

Figure D (Tepadina 5)
Packaging label for TEPADINA 100 mg/vial, an injection powder for solution containing thiotepa distributed by Amneal Pharmaceuticals LLC. The label states use for intravenous, intracavitary, or intravesical administration. It includes storage instructions, barcode, and cautionary note marking it as a cytotoxic agent. The label is produced by Adienne Pharma & Biotech with a red and blue color scheme.*
FDA Label Image

Figure E (Tepadina 6)

Figure E (Tepadina 6)
An instructional illustration labeled with numbered components (2 to 9) depicting a multi-port intravenous or infusion bag setup, including ports for infusion and medication access, a peel seal, and compartments likely representing the bag's sections. The diagram serves to identify parts of the infusion system for correct usage.*
FDA Label Image

Figure E-400mg Bag (Tepadina 7)

Figure E-400mg Bag (Tepadina 7)
An instructional diagram depicting a dual-chamber flexible container system, labeled with numeric callouts identifying parts such as ports and chambers, possibly for preparation or reconstitution of a drug solution. The illustration includes two main compartments separated by a perforated line and connectors on the top.*
FDA Label Image

Figure F (Tepadina 8)

Figure F (Tepadina 8)
An instructional diagram showing a labeled medical bag with multiple ports (numbered 2, 3, and 4) and sections (8 and 9), a peel seal labeled 6 between sections, and a depiction of hands indicating handling or preparation. Text and smaller diagrams appear in section 9, including usage warnings for the ports.*
FDA Label Image

Figure F-400mg Bag (Tepadina 9)

Figure F-400mg Bag (Tepadina 9)
An instructional diagram illustrating steps likely related to hand hygiene or preparation involving a medical bag with multiple ports numbered 2, 3, 4, 6, 8, and 9. The image shows a pair of hands being washed or scrubbed next to a container with labeled sections and connections, emphasizing procedural preparation.*
FDA Label Image

Figure G (Tepadina 10)

Figure G (Tepadina 10)
An instructional illustration showing hands performing chest compressions on a person lying down, next to a defibrillator pad. The image demonstrates the technique of manual cardiopulmonary resuscitation (CPR) compressions.*
FDA Label Image

Figure H (Tepadina 11)

Figure H (Tepadina 11)
An instructional illustration showing hands performing chest compressions, likely demonstrating CPR technique with one hand over the other.*
FDA Label Image

Figure I (Tepadina 12)

Figure I (Tepadina 12)
Two instructional illustrations show hands manipulating a vial and a sealed container labeled 'PRESS,' both marked with large black X's indicating actions that should not be performed. The images likely caution against incorrect handling or opening methods for the medication.*
FDA Label Image

Figure J (Tepadina 13)

Figure J (Tepadina 13)
An instructional illustration showing hands wearing gloves holding a flexible medical bag with connectors. The bag features a labeled "LABEL AREA" section indicating where product information should be placed. This likely represents the preparation or handling of an injection powder for solution, associated with TEPADINA (Thiotepa) by Amneal Pharmaceuticals.*
FDA Label Image

Figure K (Tepadina 14)

Figure K (Tepadina 14)
An instructional diagram showing hands manipulating a flexible bag with connectors, indicating a flow or shaking motion with arrows. The image highlights a designated 'LABEL AREA' on the bag, likely illustrating preparation or handling steps for the product.*
FDA Label Image

Figure L (Tepadina 15)

Figure L (Tepadina 15)
An instructional illustration showing two hands, one holding a component while the other is twisting or turning a part indicated by a circular arrow with the number 3, suggesting a step in a preparation or assembly process.*
FDA Label Image

Figure M (Tepadina 16)

Figure M (Tepadina 16)
An instructional illustration showing two hands manipulating a syringed vial or container. One hand holds the vial steady while the other hand twists or adjusts the syringe plunger or cap in a clockwise direction, indicated by an arrow. The image likely demonstrates a step in the preparation or administration of an injectable drug solution.*
FDA Label Image

Figure N (Tepadina 17)

Figure N (Tepadina 17)
Illustration showing a hand holding a syringe and drawing liquid from a vial or ampule. The image emphasizes proper technique for withdrawing medication using a syringe, indicated by a downward arrow guiding the flow of liquid into the syringe.*
FDA Label Image

Figure O (Tepadina 18)

Figure O (Tepadina 18)
An instructional illustration showing two hands with one hand holding a vial or ampule and the other hand snapping off the top. There is a number '4' indicating the step in the process, likely related to preparing the TEPADINA injection solution for use.*
FDA Label Image

Figure P (Tepadina 19)

Figure P (Tepadina 19)
An instructional illustration showing a gloved hand holding a vial or container with two ports, connecting a syringe or tubing to one of the ports as part of a preparation or administration procedure.*
FDA Label Image

Figure Q (Tepadina 20)

Figure Q (Tepadina 20)
An instructional illustration showing a pair of hands demonstrating a twisting motion, indicated by a curved arrow and the number 3, likely as part of step-by-step preparation or administration instructions for the TEPADINA injection powder for solution.*
FDA Label Image

Figure R (Tepadina 21)

Figure R (Tepadina 21)
An instructional illustration showing a gloved hand holding and adjusting medical tubing connected to a container, likely depicting a step in preparing or administering an intravenous or intravesical solution. The image includes a numerical label '3' near the tubing connection point.*
FDA Label Image

Figure S (Tepadina 22)

Figure S (Tepadina 22)
TEPADINA injection powder for solution packaging label. The label is monochromatic with a designated label area shown, includes a space for lot or batch number, and a gray vertical stripe along the right side with the number 7 at the top. No specific strength or detailed drug information is visible on this label portion. Labeler is Amneal Pharmaceuticals LLC.*
FDA Label Image

Thiotepa Structure (Tepadina 23)

Thiotepa Structure (Tepadina 23)
Chemical structure of thiotepa, the active ingredient in TEPADINA injection powder for solution. The structure depicts phosphoramide with three aziridine (cyclo-propane nitrogen-containing) groups attached to phosphorus with a sulfur double bond.*
FDA Label Image

15mg Vial Label (Tepadina 24)

15mg Vial Label (Tepadina 24)
Label for TEPADINA 15 mg/vial injection (thiotepa) powder for solution, for intravenous, intracavitary, or intravesical use. It is a single-dose vial and a cytotoxic agent, Rx only. Distributed by Amneal Pharmaceuticals LLC. Includes space for lot and expiration dates.*
FDA Label Image

15mg Carton (Tepadina 25)

15mg Carton (Tepadina 25)
TEPADINA 15 mg/vial (thiotepa) for injection powder for solution carton label. The label indicates use for intravenous, intracavitary, or intravesical administration. It includes storage instructions to keep refrigerated between 2°C to 8°C and a caution that it is a cytotoxic agent. The label also states the product is a single dose vial and includes a barcode and NDC 70121-1630-1. Distributed by Amneal Pharmaceuticals LLC.*
FDA Label Image

100mg Vial Label (Tepadina 26)

100mg Vial Label (Tepadina 26)
Label for TEPADINA 100 mg/vial (thiotepa) injection powder for solution. It states use for intravenous, intracavitary, or intravesical administration. The label includes a caution that TEPADINA is a cytotoxic agent and is Rx only. It is distributed by Amneal Pharmaceuticals LLC and references a single dose vial with space for lot and expiration date.*
FDA Label Image

100mg Carton (Tepadina 27)

100mg Carton (Tepadina 27)
Packaging label for TEPADINA 100 mg/vial injection powder, generic name thiotepa, for intravenous, intracavitary, or intravesical use. The label includes storage instructions, distributor information (Amneal Pharmaceuticals LLC), barcode, and warnings indicating the product is a single-dose vial and a cytotoxic agent. The label design features blue and red text with ADIENNE Pharma & Biotech branding.*
FDA Label Image

200mg Label (Tepadina 28)

200mg Label (Tepadina 28)
Label for TEPADINA 200 mg bag, an injection powder for solution containing thiotepa. The label is designed for intravenous infusion after activation and includes instructions for storage, activation, and usage warnings. The product is distributed by Amneal Pharmaceuticals LLC.*
FDA Label Image

200mg Carton (Tepadina 29)

200mg Carton (Tepadina 29)
Packaging label for TEPADINA 200 mg/ bag injection powder (thiotepa) for solution, distributed by Amneal Pharmaceuticals LLC. The label indicates the product is for intravenous infusion after activation and is a single-dose container. It includes storage instructions, a warning that it is a hazardous drug, and the NDC number 70121-2749-1.*
FDA Label Image

400mg Label (Tepadina 30)

400mg Label (Tepadina 30)
TEPADINA 400 mg injection powder for solution label for intravenous infusion. The label indicates a multichamber flexible bag containing 400 mg thiotepa with 400 mL 0.9% Sodium Chloride Injection. Distributed by Amneal Pharmaceuticals LLC. Includes storage instructions to keep refrigerated between 2°C to 8°C and discard after specified times. Contains a barcode and patent information.*
FDA Label Image

400mg Bag Carton (Tepadina 31)

400mg Bag Carton (Tepadina 31)
Packaging label for TEPADINA (thiotepa) injection powder for solution, 400 mg per bag. The label indicates it is for intravenous infusion after activation and is a single-dose container with instructions to discard unused portions. It is marked as a hazardous drug and distributed by Amneal Pharmaceuticals LLC. The package includes storage and handling instructions and displays the NDC 70121-1687-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.